BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2020
View Archived Issues
MTX-COVAB shows potent therapeutic and prophylactic activity in mode of advanced COVID-19
Read More
Enrollment ongoing in phase I study of BAY-1211163 in ARDS
Read More
Precision BioSciences reports interim phase I/II data on PBCAR-0191
Read More
AstraZeneca initiates first-in-human phase I study of AZD-3427
Read More
Lilly and UnitedHealth collaborate on pragmatic study of bamlanivimab for COVID-19
Read More
Interim analysis supports continuation of phase II/III GAIN trial of atuzaginstat in AD
Read More
CC Biotech describes new polypeptides for treating bacterial infections
Read More
New MAPK 1 inhibitors identified at Medshine Discovery
Read More
Ascentawits Pharmaceuticals discovers AKR1C3-activatable DNA alkylating drugs
Read More
Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent RET inhibitors
Read More
New IDO-1 inhibitors synthesized at Hutchison MediPharma
Read More
mRNA SARS-CoV-2 vaccines to usher in 'golden age of vaccinology'
Read More
Kinase inhibitor for hearing loss protection
Read More
Data from phase II studies of VAL-083 in glioblastoma
Read More
FDA approves Saxenda to treat obesity in adolescents
Read More
Preliminary activity seen with ianalumab plus ibrutinib in relapsed/refractory CLL
Read More
Phase III study of maribavir to treat transplant recipients for CMV infection meets primary endpoint
Read More
FDA approves IND for Alligator's mitazalimab
Read More
Early phase I results show AVID-200 is well tolerated in myelofibrosis patients
Read More
HOOKIPA reports interim phase I data on HB-201 for HPV16+ cancers
Read More
New vulnerability in "KL" KRAS subtype
Read More
DoD grant to support evaluation of BXCL-501 for PTSD
Read More
FDA places clinical hold on phase I/II study of BPX-601
Read More
